← Back to Clinical Trials
Recruiting NCT07147205

NCT07147205 Evaluation of Meaning-centered Group Psychotherapy in Integrative Medicine

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07147205
Status Recruiting
Phase
Sponsor M.D. Anderson Cancer Center
Condition Psychotherapy
Study Type INTERVENTIONAL
Enrollment 72 participants
Start Date 2025-10-03
Primary Completion 2027-02-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 72 participants in total. It began in 2025-10-03 with a primary completion date of 2027-02-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

To learn more about your experience participating in a virtual Meaning-Centered Psychotherapy group.

Eligibility Criteria

Eligibility Criteria 1. Age 18 or older. 2. Male or female. 3. Diagnosis or history of malignant cancer (excluding non-melanoma skin cancer) or tumor disease. 4. Able to read, write, and speak in English. 5. Has access to iOS or Android smartphone, computer, or tablet or device capable of logging onto Zoom. 6. Referred to the Integrative Medicine Clinic, completed consult with IMC physician, referred to health psychology and completed health psychology assessment. 7. Participates in at least one MCGP group session. 8. Willing to review informed consent statement and agree to complete questionnaires. Exclusion Criteria 1. Children will not be enrolled in this study. 2. Pregnant women will not be enrolled in this study. 3. Cognitively impaired subjects will not be enrolled in this study.

Contact & Investigator

Central Contact

Elizabeth C Conti, MD

✉ ecconti@mdanderson.org

📞 7135637630

Principal Investigator

Elizabeth C Conti, MD

PRINCIPAL INVESTIGATOR

M.D. Anderson Cancer Center

Frequently Asked Questions

Who can join the NCT07147205 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Psychotherapy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07147205 currently recruiting?

Yes, NCT07147205 is actively recruiting participants. Contact the research team at ecconti@mdanderson.org for enrollment information.

Where is the NCT07147205 trial being conducted?

This trial is being conducted at Houston, United States.

Who is sponsoring the NCT07147205 clinical trial?

NCT07147205 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Elizabeth C Conti, MD at M.D. Anderson Cancer Center. The trial plans to enroll 72 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology